Home › Lipoid Nephrosis › North Carolina
Lipoid Nephrosis clinical trials in North Carolina
4 studies for Lipoid Nephrosis are looking for participants at sites in North Carolina.
Cities in North Carolina
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
- UNC Kidney Center- Site Number : 8400021, Chapel Hill
RecruitingPhase 2
Ages 16 to 75 · All sexes · Updated Sep 23, 2026 · NCT06500702Nephrotic Syndrome Study Network
- University of North Carolina at Chapel Hill, Chapel Hill
- Atrium Health Levine Children's Hospital, Charlotte
RecruitingObservational study
Up to age 80 · All sexes · Updated Jun 10, 2026 · NCT01209000NEPTUNE Match Study
- University of North Carolina Chapel Hill, Chapel Hill
Recruiting
Ages 1 to 80 · All sexes · Updated Jun 10, 2026 · NCT04571658Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- University of North Carolina at Chapel Hill, Chapel Hill
- Duke Molecular Physiology Institute, Durham
RecruitingPhase 2
Ages 1 to 17 · All sexes · Updated May 12, 2026 · NCT05003986From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.